Peer support plus incentives to reduce harms from methamphetamine use
Peer Engagement in Methamphetamine Harm-Reduction with Contingency Management (PEER-CM)
This project offers peer support plus small rewards to help people who use methamphetamine reduce overdose risk and connect to harm-reduction services.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11364655 on NIH RePORTER |
What this research studies
You would work with trained peer recovery specialists to set your own harm-reduction goals and get help reaching them. Some people in the program earn small rewards when they meet those personal goals, while others receive the usual peer support with incentives for visits. The study tracks whether offering rewards for goal achievement leads to more use of harm-reduction services and fewer overdoses. The work uses a network of peer harm-reduction organizations in Oregon to reach people who might not be in formal treatment.
Who could benefit from this research
Good fit: Ideal participants are adults who currently use methamphetamine, especially those at risk of fentanyl exposure or not engaged in formal treatment, and who can access peer organizations in Oregon.
Not a fit: People who do not use methamphetamine, are already stably engaged in treatment with no unmet harm-reduction needs, or who cannot access Oregon-based peer sites may not benefit.
Why it matters
Potential benefit: If it works, this approach could reduce overdoses and make it easier for people who use methamphetamine to get harm-reduction help.
How similar studies have performed: Contingency management has helped reduce stimulant use in prior trials, but pairing it with outreach by peer recovery specialists for methamphetamine and fentanyl risk is a newer approach.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Korthuis, Philip Todd — Oregon Health & Science University
- Study coordinator: Korthuis, Philip Todd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.